CellaVision AB (LTS:0MR5)
kr 239.25 0 (0%) Market Cap: 5.80 Bil Enterprise Value: 5.69 Bil PE Ratio: 37.03 PB Ratio: 7.24 GF Score: 93/100

Q1 2022 CellaVision AB Earnings Call Transcript

May 10, 2022 / 09:00AM GMT
Release Date Price: kr309 (+0.16%)
Operator

Welcome to CellaVision Audiocast Teleconference Q1 2022. Today, I am pleased to present CEO, Simon Ostergaard; and CFO, Magnus Blixt. (Operator Instructions) I'll now hand the floor to our speakers.

Simon Ostergaard;publ;CEO;President
CellaVision AB

()-&

Thank you very much. So this is Simon Ostergaard speaking here, CEO; and I have Magnus Blixt, our CFO, with me. Thank you very much for taking the time to listening to our first quarterly update here in 2022. We will get right into it this time around. So we will hop into our first quarter quarterly update with highlights. So we can take the next slide.

The key line for our quarterly report here is that we're off to a strong start to 2012 -- 2022, of course. We had net sales of SEK 162 million, which represents a total growth of 21%. The sales increased organically by 15%. So we had currency effect of 6%. So as said, a pretty strong quarter up against compares other years.

From a strategic perspective, some of the key points here is that I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot